Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis

Li, Xiaojuan; Wei, Yulei; Xu, Zhe; Li, Tiewei; Dong, Geng; Liu, Xinrui; Zhu, Zhiwei; Yang, Jianwei; Yang, Junmei

doi:https://doi.org/10.1155/2023/9077787

Mediators of Inflammation

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Abbreviations Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 9077787 | https://doi.org/10.1155/2023/9077787

Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis

Xiaojuan Li,¹Yulei Wei,¹Zhe Xu,¹Tiewei Li,^1,2Geng Dong,¹Xinrui Liu,¹Zhiwei Zhu,¹Jianwei Yang,¹and Junmei Yang¹

Academic Editor: Daniela Caccamo

Received20 May 2022

Revised03 Aug 2022

Accepted26 Apr 2023

Published08 May 2023

Abstract

Background. Neonatal sepsis is an extremely dangerous and fatal disease among neonates, and its timely diagnosis is critical to treatment. This research is aimed at evaluating the clinical significance of the lymphocyte-to-C-reactive protein ratio (LCR) as an early sepsis indicator in neonates with suspected sepsis. Methods. Between January 2016 and December 2021, 1269 neonates suspected of developing sepsis were included in this research. Among them, sepsis was diagnosed in 819 neonates, with 448 severe cases, as per the International Pediatric Sepsis Consensus. Data related to clinical and laboratory tests were obtained via electronic medical records. LCR was calculated as total lymphocyte (109 cells/L)/C-reactive protein (mg/L). Multivariate logistic regression analysis was employed to evaluate the effectiveness of LCR as an independent indicator for determining sepsis in susceptible sepsis neonates. Receiver operating characteristic (ROC) curve analysis was conducted for investigating the diagnostic significance of LCR in sepsis. When suitable, the statistical tool SPSS 24.0 was used for statistical analyses. Results. LCR decreased significantly in the control, mild, and severe sepsis groups. Further analyses exhibited that there was a substantially greater incidence of sepsis in neonates in the low-LCR group () as opposed to the higher LCR group () (77.6% vs. 51.4%, ). Correlation analysis indicated a substantial negative association of LCR with procalcitonin (, ) and hospital stay duration (, ). Multiple logistic regression analysis depicted LCR as an independent indicator for identifying sepsis and severe cases of this disease. ROC curve analysis indicated the optimal cutoff value of LCR in identifying sepsis to be 2.10, with 88% sensitivity and 55% specificity. Conclusions. LCR has proven to be a potentially strong biomarker capable of identifying sepsis in a timely manner in neonates suspected to have the disease.

1. Introduction

Compared with children and adults, neonates are more susceptible to pathogenic infections as their immune system is still developing. These infections may develop into sepsis [1]. The health and lives of neonates around the world are significantly threatened by neonatal sepsis, a systemic inflammatory response syndrome (SIRS) characterized by pathological inflammatory responses and organ system dysfunction [2]. Fleischmann-Struzek et al. [3] described that neonatal sepsis was estimated to affect 2202 out of every 100,000 live births, with a death rate of 11% to 19%. As a result, prompt and accurate diagnosis of neonatal sepsis is crucial for effective care. Currently, blood culture is used to diagnose neonatal sepsis [4]. However, the accuracy of blood culture depends on certain factors, such as blood volume, level of bacteremia, and prenatal and prehospital antibiotic use, which may result in a low positive rate of the blood culture [5]. In addition, the clinical presentation of sepsis is similar to other common neonatal diseases. Hence, finding novel biomarkers for neonatal sepsis is crucial.

In sepsis, multiple anti-inflammatory cytokines are released into the blood, further causing immunosuppression and subsequently leading to the apoptosis of many lymphocytes [6–8]. Several studies reported that lymphocytopenia was frequently observed in sepsis-affected individuals and was linked to poor outcomes [9–12]. When the body is inflamed or infected, the liver produces more C-reactive protein (CRP), an acute inflammatory protein [13]. Research has shown that CRP is a significant indicator of sepsis risk and a predictor in neonates and adults [14–17]. The lymphocyte-to-C-reactive protein ratio (LCR) is an index measured as the total lymphocyte count (TLC) level divided by the CRP level. Sepsis decreases lymphocyte counts and increases the CRP level [18, 19]. Therefore, this study proposed that LCR might be decreased in sepsis-affected neonates and thus can serve as a biomarker for identifying neonatal sepsis. Nevertheless, only a few studies have assessed the significance of LCR for this purpose. Thus, the primary goal of this research was to examine the clinical involvement of LCR in detecting neonatal sepsis.

2. Materials and Methods

2.1. Study Design and Population

This was a retrospective, single-center observational research that was carried out at the Henan Children’s Hospital, Zhengzhou, China, between January 2016 and December 2021. Inclusion criteria for the study were neonates with suspected sepsis upon admission whose age is ≤28 days. Exclusion criteria were patients with a compromised immune system (liver failure, autoimmune diseases, and hematological cancer), cancer patients, or individuals suffering from severe congenital diseases. The study protocol was approved by the Hospital Ethics Review Board of the Henan Children’s Hospital (no. 2022-K-105). Every research technique employed in this study was regarded as part of regular clinical practice, and the information was kept anonymous. Thus, considering the retrospective nature of the current investigation, informed consent was not required.

2.2. Clinical Definition

Neonates with suspected sepsis generally have one or more of the conditions mentioned as follows: respiratory distress, poor feeding, unstable body temperature, bradycardia, and abnormal white blood cells. The term “neonatal sepsis” refers to a systemic inflammatory response syndrome that includes a possible or confirmed infection. Severe sepsis can be described as sepsis combined with one of the following conditions: cardiovascular organ dysfunction, acute respiratory distress syndrome, or two or more other organ dysfunctions. As described by the published International Pediatric Sepsis Consensus, both neonatal sepsis and severe sepsis were diagnosed by two independent clinicians [20]. The control group included neonates with suspected sepsis who were eventually ruled out as they did not develop sepsis.

2.3. Data Collection

Data (demographics and laboratory tests) regarding patient age, gender, weight, body temperature, respiratory and heart rates, systolic and diastolic blood pressures, hospital stay duration, and procalcitonin (PCT), C-reactive protein (CRP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) levels were obtained via electronic medical records at the time of admission. Serum PCT concentration was calculated by employing the Cobas® 8000 modular analyzer (Roche Diagnostics, Switzerland). A latex-enhanced immunoturbidimetric assay on an UPPER analyzer (Ultrasensitive CRP kit, Upper Biotech, China) was utilized for the measurement of CRP levels. On an automatic Beckman biochemical analyzer (Beckman Coulter, California), the conventional clinical analytical approach was used to measure ALT, AST, and ALB levels. An automated blood cell counter (Sysmex Corporation, Japan) was employed to measure the white blood cell, neutrophil, and lymphocyte counts. In this study, were measured to be 0.7 mg/L. or <0.02 ng/mL were measured as 101 ng/mL and 0.01 ng/mL, respectively. LCR was TLC (10⁹ cells/L)/CRP (mg/L).

2.4. Statistical Analysis

Independent -tests or a one-way analysis of variance (ANOVA) was utilized for the assessment of normally distributed variables, which were reported as the (SD). Non-normally distributed variables were expressed as medians (interquartile range) and assessed by employing the Mann-Whitney test. Categorical variables were presented as percentages and evaluated via chi-square tests. Spearman’s correlation test was employed to evaluate the association of LCR with other continuous variables. To determine the independent risk factor for the occurrence of severe sepsis and neonatal sepsis, multiple logistic regression analysis was applied, and it included variables having a value < 0.05 in the univariate logistic analysis. Receiver operating characteristic (ROC) curve analysis was carried out for evaluation of the diagnostic significance of LCR in identifying neonatal sepsis. A comparison of the area under ROC curves (AUC) between two variables was done with the help of DeLong’s test. The optimal cutoff point of LCR for identifying sepsis in neonates was calculated via Youden’s index () [21]. The SPSS version 24.0 (USA) and MedCalc version 15.2.2 (MedCalc Software, Belgium) were employed for analyzing all the data. A two-sided value < 0.05 was deemed statistically significant.

3. Results

3.1. Study Population Characteristics

This research involved 1269 neonates with suspected sepsis. Among those neonates, 819 (64.5%) neonates were diagnosed with sepsis, of which, 371 (45.3%) were diagnosed as mild and 448 (54.7%) as severe. The remaining 450 (35.5%) neonates who did not develop sepsis were included in the control group. The baseline neonatal characteristics are summarized in Table 1. Unlike the control group, sepsis-affected neonates were older; had higher body weight, body temperature, and respiratory and heart rates; and had a lengthier hospital stay. Biochemical analysis and white blood cell count depicted that sepsis-affected neonates had increased PCT, CRP, ALT, and neutrophil count and lowered levels of ALB, lymphocyte count, and LCR. Furthermore, the differences in the above-related indexes among all three study groups were also analyzed. The PCT and CRP levels and the hospital stay duration exhibited a steady rise, and ALB and LCR levels gradually declined in all three study groups, according to the findings.

3.2. Association of LCR with Clinical Parameters

For the purpose of further evaluating the association of LCR with other clinical parameters, Spearman correlation analysis was conducted. As depicted in Table 2, LCR had a positive link to age (, ), weight (, ), ALB (, ), and WBC (, ) and a negative link to the body temperature (, ), respiratory rate (, ), heart rate (, ), PCT (, ), and neutrophil count (, ). Moreover, a positive association of LCR was observed with hospital stay duration (, ).

3.3. Independence of LCR in Identifying Neonatal Sepsis

Univariate and multivariable logistic analyses were carried out for assessing the clinical significance of LCR in predicting sepsis in neonates with suspected cases. The univariate logistic analysis showed that age, temperature, heart and respiratory rates, body weight, PCT, total neutrophil count, AST, ALT, and LCR were possible predictors for neonatal sepsis. After adjusting these statistically significant predictors of the univariate analysis, LCR was still an independent biomarker for neonatal sepsis (, 95% CI 0.824–0.899, ) and severe sepsis (, 95% CI 0.898–0.975, ). The data exhibited a negative and independent association of LCR with sepsis in neonates (Table 3).

3.4. Diagnostic Significance of LCR in Neonatal Sepsis

ROC curve analysis was conducted for assessing the diagnostic significance of LCR in identifying sepsis in neonates. As depicted in Figure 1, the AUC for LCR in identifying neonatal sepsis was 0.70 (95% CI, 0.67–0.73, ), which was higher than the AUC for lymphocyte count (, 95% CI, 0.57–0.63, ) and CRP (, 95% CI, 0.63–0.69, ) (). The optimal cutoff value of LCR in identifying neonatal sepsis was 2.10, with 88% sensitivity and 55% specificity. As per the cutoff value of LCR, two groups of neonates were established: the low-LCR group () and the high-LCR group (). As depicted in Table 4, there were 373 (87.4%) sepsis-affected neonates in the low-LCR group and 446 (53.0%) neonates without sepsis. The percentage of sepsis-affected neonates in the low-LCR group was substantially greater as opposed to that in the high-LCR group (Figure 2). Furthermore, analytic findings indicated the percentage of mild and severe sepsis-affected individuals to be elevated in the low-LCR group as opposed to the other group (Figure 2).

4. Discussion

Neonatal sepsis, also described as systemic inflammatory response syndrome, is a highly morbid and fatal condition with a bacterial, viral, or fungal origin characterized by hemodynamic alterations and clinical symptoms [22]. In a study involving 194 countries conducted between 2000 and 2013, Oza et al. [23] reported that neonatal sepsis accounted for the third highest number of neonate deaths following preterm birth and intrapartum complications, accounting for 15.6% of neonate fatalities. During the late neonatal period (7–27 days), the sepsis-associated death rate rose to 37.2% [23]. Accurate and timely diagnosis of sepsis in neonates can improve the clinical treatment of the condition and lessen antibiotic misuse. Currently available diagnostic techniques for neonatal sepsis depend on conventional blood culture, which is inefficient. Its findings may be affected by multiple factors, such as insufficient blood samples, administration of antibiotics prior to sampling, reduced bacteria in the blood, or short-term bacteremia. Moreover, sepsis symptoms in neonates are quite generalized [24]. Therefore, identifying new biomarkers of neonatal sepsis is important.

Lymphocytes are a type of white blood cell produced in the bone marrow. In the body, these cells fight off bacterial and viral infections. However, with sepsis, there is extensive apoptotic death of lymphocytes [8]. An essential stage in the onset of experimental sepsis has been identified as lymphocyte apoptosis. This process can further induce a state of immunosuppression, which increases host susceptibility to invading pathogens [8, 25, 26]. Meanwhile, several studies reported that peripheral blood lymphocyte count decreased in patients with sepsis, and lymphopenia was associated with poor outcomes [10, 27–29]. CRP was one of the most studied and frequently used inflammation markers. As a traditional inflammatory marker, CRP has proven its potential as an independent sepsis risk factor [15, 16, 30]. However, Pradhan et al. [31] found that CRP is a sensitive marker of sepsis, but not specific. For neonatal sepsis, the sensitivities and specificities of CRP in diagnosing sepsis ranged from 29% to 100% and from 6% to 100%, respectively [32]. During this research, the data also exhibited a high sensitivity (93%) and a low specificity (37%) of CRP in diagnosing neonatal sepsis (data not shown).

Recently, as an emerging marker of systemic inflammation, LCR has received increasing attention. Particularly in cancer, this ratio is more sensitive during the acute inflammatory phase. Studies have demonstrated that LCR is a safe and effective postsurgical prognostic biomarker of postoperative complications in patients with gastric cancer, esophageal cancer, colorectal cancer, and hepatocellular carcinoma [33–37]. In terms of infectious diseases, recent studies found that LCR was closely related to the coronavirus disease 2019 (COVID-19) [38, 39]. Yang et al. [40] reported that LCR proved more beneficial as opposed to CRP or lymphocytes alone in the assessment of severe COVID-19. In the timely identification and anticipation of the severity and fatality of COVID-19, the CRP-to-lymphocyte ratio (CLR) may be a helpful prognostic indicator. However, the relationship of LCR with sepsis in adults and neonates has received little attention from published research.

During this research, the association of LCR with neonatal sepsis was initially studied. It was observed that sepsis-affected neonates had reduced levels of LCR, and these values were reduced gradually within all three study groups. Multivariate analysis exhibited the potential of LCR as an independent predictor in distinguishing septic neonates from neonates with suspected sepsis. ROC curve analysis depicted the better discriminatory capability of LCR in contrast with lymphocyte count and CRP in identifying neonatal sepsis. The optimal cutoff value of LCR in diagnosing sepsis among neonates was 2.10, with 88% sensitivity and 55% specificity. Using the optimal cutoff value, the neonates were further stratified into two groups, and it was observed that the low-LCR group exhibited an increased occurrence of neonatal sepsis (87.4%) and had a low percentage of controls (12.6%).

There are several limitations to this research. Because this is a retrospective single-center observational study, additional confounding factors could affect the results no matter how many exclusion criteria are used. In addition, multicenter clinical investigations are required in the future to confirm the findings. All neonates with a final diagnosis of sepsis were clinical sepsis. As a result, it is possible that the actual incidence rate of neonatal sepsis is overestimated or underestimated. Additionally, LCR was only calculated when patients were admitted to the hospital, and serial measurements of LCR might offer more effective monitoring of the relationship between LCR and neonatal sepsis.

5. Conclusions

The present study has proven that LCR is a useful biomarker in distinguishing septic neonates from neonates with suspected sepsis. These findings highlight that LCR, which can be measured and calculated easily, quickly, and cost-effectively, can serve as a promising alternative way of efficiently identifying neonatal sepsis.

Abbreviations

SBP:	Systolic blood pressure
DBP:	Diastolic blood pressure
PCT:	Procalcitonin
CRP:	C-reactive protein
ALB:	Albumin
ALT:	Alanine aminotransferase
AST:	Aspartate aminotransferase
WBC:	White blood cell
LCR:	Lymphocyte-to-C-reactive protein ratio.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Ethical Approval

The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Hospital Ethics Review Board of Henan Children’s Hospital (no. 2022-K-105).

The study guarantees that the identity of the participants and other related data are kept anonymous and confidential; therefore, the requirement for informed consent has been waived because of the retrospective nature of the current study.

Conflicts of Interest

The authors report no conflicts of interest.

Authors’ Contributions

Tiewei Li and Xiaojuan Li were responsible for the data collection, statistical analysis, and manuscript writing. Yulei Wei, Zhe Xu, Geng Dong, Xinrui Liu, Zhiwei Zhu, Jianwei Yang, and Junmei Yang were responsible for the data collection and funding acquisition. Tiewei Li was responsible for the project administration, manuscript review, and editing. All authors read and approved the final manuscript. Xiaojuan Li and Tiewei Li contributed equally to this work and considered as co-first authors.

Acknowledgments

This work was funded by the Key Research, Development, and Promotion Projects of Henan Province (222102310067 and 232102310122), the Medical Science and Technology Project of Henan Province (LHGJ20210637, LHGJ20210665, LHGJ20210654, LHGJ20210672, and LHGJ20200666), and the Open Project of Henan Children’s Neurodevelopment Engineering Research Center (SG201901).

References

A. Camacho-Gonzalez, P. W. Spearman, and B. J. Stoll, “Neonatal infectious diseases: evaluation of neonatal sepsis,” Pediatric Clinics of North America, vol. 60, no. 2, pp. 367–389, 2013.
View at: Publisher Site | Google Scholar
A. L. Shane, P. J. Sánchez, and B. J. Stoll, “Neonatal sepsis,” Lancet, vol. 390, no. 10104, pp. 1770–1780, 2017.
View at: Publisher Site | Google Scholar
C. Fleischmann-Struzek, D. M. Goldfarb, P. Schlattmann, L. J. Schlapbach, K. Reinhart, and N. Kissoon, “The global burden of paediatric and neonatal sepsis: a systematic review,” The Lancet Respiratory Medicine, vol. 6, no. 3, pp. 223–230, 2018.
View at: Publisher Site | Google Scholar
P. Y. Iroh Tam and C. M. Bendel, “Diagnostics for neonatal sepsis: current approaches and future directions,” Pediatric Research, vol. 82, no. 4, pp. 574–583, 2017.
View at: Publisher Site | Google Scholar
A. Zea-Vera and T. J. Ochoa, “Challenges in the diagnosis and management of neonatal sepsis,” Journal of Tropical Pediatrics, vol. 61, no. 1, pp. 1–13, 2015.
View at: Publisher Site | Google Scholar
D. S. Heffernan, S. F. Monaghan, R. K. Thakkar, J. T. Machan, W. G. Cioffi, and A. Ayala, “Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern,” Critical Care, vol. 16, no. 1, article R12, 2012.
View at: Publisher Site | Google Scholar
T. Menges, J. Engel, I. Welters et al., “Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications,” Critical Care Medicine, vol. 27, no. 4, pp. 733–740, 1999.
View at: Publisher Site | Google Scholar
R. S. Hotchkiss, S. B. Osmon, K. C. Chang, T. H. Wagner, C. M. Coopersmith, and I. E. Karl, “Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways,” Journal of Immunology, vol. 174, no. 8, pp. 5110–5118, 2005.
View at: Publisher Site | Google Scholar
J. S. Boomer, J. Shuherk-Shaffer, R. S. Hotchkiss, and J. M. Green, “A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis,” Critical Care, vol. 16, no. 3, article R112, 2012.
View at: Publisher Site | Google Scholar
A. M. Drewry, N. Samra, L. P. Skrupky, B. M. Fuller, S. M. Compton, and R. S. Hotchkiss, “Persistent lymphopenia after diagnosis of sepsis predicts mortality,” Shock, vol. 42, no. 5, pp. 383–391, 2014.
View at: Publisher Site | Google Scholar
K. P. Chung, H. T. Chang, S. C. Lo et al., “Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis,” Shock, vol. 43, no. 6, pp. 569–575, 2015.
View at: Publisher Site | Google Scholar
H. Sheikh Motahar Vahedi, A. Bagheri, A. Jahanshir, J. Seyedhosseini, and E. Vahidi, “Association of lymphopenia with short term outcomes of sepsis patients; a brief report,” Archives of Academic Emergency Medicine, vol. 7, no. 1, article e14, 2019.
View at: Google Scholar
N. R. Sproston and J. J. Ashworth, “Role of C-reactive protein at sites of inflammation and infection,” Frontiers in Immunology, vol. 9, p. 754, 2018.
View at: Publisher Site | Google Scholar
M. Stocker, W. van Herk, S. el Helou et al., “C-reactive protein, procalcitonin, and white blood count to rule out neonatal early-onset sepsis within 36 hours: a secondary analysis of the neonatal procalcitonin intervention study,” Clinical Infectious Diseases, vol. 73, no. 2, pp. e383–e390, 2021.
View at: Publisher Site | Google Scholar
P. Póvoa, E. Almeida, P. Moreira et al., “C-reactive protein as an indicator of sepsis,” Intensive Care Medicine, vol. 24, no. 10, pp. 1052–1056, 1998.
View at: Publisher Site | Google Scholar
H. E. Wang, N. I. Shapiro, M. M. Safford et al., “High-sensitivity C-reactive protein and risk of sepsis,” PLoS One, vol. 8, no. 7, article e69232, 2013.
View at: Publisher Site | Google Scholar
Y. Yu, W. Wu, Y. Dong, and J. Li, “C-reactive protein-to-albumin ratio predicts sepsis and prognosis in patients with severe burn injury,” Mediators of Inflammation, vol. 2021, Article ID 6621101, 9 pages, 2021.
View at: Publisher Site | Google Scholar
T. Li, G. Dong, M. Zhang et al., “Association of Neutrophil–Lymphocyte Ratio and the Presence of Neonatal Sepsis,” Journal of Immunology Research, vol. 2020, Article ID 7650713, 8 pages, 2020.
View at: Publisher Site | Google Scholar
T. Li, X. Li, Y. Wei et al., “Predictive value of C-reactive protein-to-albumin ratio for neonatal sepsis,” Journal of Inflammation Research, vol. 14, pp. 3207–3215, 2021.
View at: Publisher Site | Google Scholar
B. Goldstein, B. Giroir, A. Randolph, and International Consensus Conference on Pediatric Sepsis, “International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics,” Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol. 6, no. 1, pp. 2–8, 2005.
View at: Publisher Site | Google Scholar
G. Hughes, “Youden's index and the weight of evidence,” Methods of Information in Medicine, vol. 54, no. 2, pp. 198-199, 2015.
View at: Publisher Site | Google Scholar
F. Kim, R. A. Polin, and T. A. Hooven, “Neonatal sepsis,” BMJ, vol. 371, 2020.
View at: Publisher Site | Google Scholar
S. Oza, J. E. Lawn, D. R. Hogan, C. Mathers, and S. N. Cousens, “Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000-2013,” Bulletin of the World Health Organization, vol. 93, no. 1, pp. 19–28, 2015.
View at: Publisher Site | Google Scholar
I. H. Celik, M. Hanna, F. E. Canpolat, and P. Mohan, “Diagnosis of neonatal sepsis: the past, present and future,” Pediatric Research, vol. 91, no. 2, pp. 337–350, 2022.
View at: Publisher Site | Google Scholar
J. D. Lang and G. Matute-Bello, “Lymphocytes, apoptosis and sepsis: making the jump from mice to humans,” Critical Care, vol. 13, no. 1, p. 109, 2009.
View at: Publisher Site | Google Scholar
C. M. Chu, L. C. Chiu, C. C. Yu et al., “Increased death of peripheral blood mononuclear cells after TLR4 inhibition in sepsis is not via TNF/TNF receptor-mediated apoptotic pathway,” Mediators of Inflammation, vol. 2021, Article ID 255017, 9 pages, 2021.
View at: Publisher Site | Google Scholar
T. Li, M. Qi, G. Dong et al., “Clinical value of prognostic nutritional index in prediction of the presence and severity of neonatal sepsis,” Journal of Inflammation Research, vol. 14, pp. 7181–7190, 2021.
View at: Publisher Site | Google Scholar
H. Liu, G. Liu, and Z. Tian, “Changes in blood lymphocytes in sepsis patients,” Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, vol. 26, no. 3, pp. 148–152, 2014.
View at: Google Scholar
C. Cilloniz, H. J. Peroni, A. Gabarrús et al., “Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis,” Open Forum Infectious Diseases, vol. 8, no. 6, 2021.
View at: Publisher Site | Google Scholar
T. Tian, B. Wei, and J. Wang, “Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis,” BMC Emergency Medicine, vol. 21, no. 1, p. 81, 2021.
View at: Publisher Site | Google Scholar
S. Pradhan, A. Ghimire, B. Bhattarai et al., “The role of C-reactive protein as a diagnostic predictor of sepsis in a multidisciplinary intensive care unit of a tertiary care center in Nepal,” Indian J Crit Care Med, vol. 20, no. 7, pp. 417–420, 2016.
View at: Publisher Site | Google Scholar
N. Hofer, E. Zacharias, W. Muller, and B. Resch, “An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks,” Neonatology, vol. 102, no. 1, pp. 25–36, 2012.
View at: Publisher Site | Google Scholar
M. Takeuchi, H. Kawakubo, S. Hoshino et al., “Lymphocyte-to-C-reactive protein ratio as a novel marker for predicting oncological outcomes in patients with esophageal cancer,” World Journal of Surgery, vol. 45, no. 11, pp. 3370–3377, 2021.
View at: Publisher Site | Google Scholar
Y. Okugawa, Y. Toiyama, A. Yamamoto et al., “Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer,” Annals of Surgery, vol. 272, no. 2, pp. 342–351, 2020.
View at: Publisher Site | Google Scholar
Y. S. Angin, M. Yildirim, F. Dasiran, and I. Okan, “Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?” ANZ Journal of Surgery, vol. 91, no. 7-8, pp. 1521–1527, 2021.
View at: Publisher Site | Google Scholar
N. Iseda, S. Itoh, T. Yoshizumi et al., “Lymphocyte-to-c-reactive protein ratio as a prognostic factor for hepatocellular carcinoma,” International Journal of Clinical Oncology, vol. 26, no. 10, pp. 1890–1900, 2021.
View at: Publisher Site | Google Scholar
M. Yildirim and B. Koca, “Lymphocyte c-reactive protein ratio: a new biomarker to predict early complications after gastrointestinal oncologic surgery,” Cancer Biomarkers, vol. 31, no. 4, pp. 409–417, 2021.
View at: Publisher Site | Google Scholar
C. Cillóniz, A. Torres, C. Garcia-Vidal et al., “Valor del ratio proteina C-reactiva-linfocitos para predecir la gravedad de la neumonia causada por SARS-CoV-2,” Archivos de Bronconeumología, vol. 57, pp. 79–82, 2021.
View at: Publisher Site | Google Scholar
W. Ullah, B. Basyal, S. Tariq et al., “Lymphocyte-to-c-reactive protein ratio: a novel predictor of adverse outcomes in COVID-19,” Journal of Clinical Medical Research, vol. 12, no. 7, pp. 415–422, 2020.
View at: Publisher Site | Google Scholar
M. Yang, X. Chen, and Y. Xu, “A retrospective study of the C-reactive protein to lymphocyte ratio and disease severity in 108 patients with early COVID-19 pneumonia from January to March 2020 in Wuhan, China,” Medical Science Monitor, vol. 26, article e926393, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Xiaojuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

480

Downloads

428

Citations